Skip to main content
. 2007 May;3(5):381–390.

Table 6.

Incidence of Infusion Reactions by Study Site

Gastroenterology site Number of patients, n Number of infusions, n Pretreated first infusions, n (%) Pretreated any infusions, n (%) Infusion reactions at first infusion, n (%) Infusion reactions at any infusion, n (%) Patients on immunosuppressives, n (%) Most common pretreatment protocol*
1 60 934 8 (13.3) 92 (9.9) 0 13 (1.4) 44 (73.3) 4
2 37 589 31 (83.8) 578 (98.1) 2 (5.4) 9 (1.5) 22 (59.5) 1
3 50 1,017 3 (6.0) 674 (66.3) 3 (6.0) 52 (5.1) 31 (62.0) 2
4 34 581 30 (88.2) 494 (85.0) 0 2 (0.3) 26 (76.5) 2
5 44 543 44 (100.0) 543 (100.0) 0 3 (0.6) 38 (86.4) 1
6 64 701 63 (98.4) 689 (98.3) 2 (3.1) 40 (5.7) 38 (59.4) 3
7 45 434 3 (6.7) 97 (22.4) 0 19 (4.4) 40 (88.9) 4
8 60 865 1 (1.7) 235 (27.2) 4 (6.7) 67 (7.7) 41 (68.3) 4
9 42 600 2 (4.8) 134 (22.3) 4 (9.5) 18 (3.0) 32 (76.2) 5
Other sites 11 204 5 (45.5) 88 (43.1) 0 3 (1.5) 10 (90.9) NA
Total 447 6,468t 190 (42.5) 3,624 (56.0) 15 (3.4) 226 (3.5) 322 (72.0) NA
*

Most common pretreatment protocol used at each site: 1: acetaminophen, nonsedating antihistamine; 2: acetaminophen, standard antihistamine; 3: acetaminophen, standard antihistamine, H2-antagonist; 4: acetaminophen, standard antihistamine, corticosteroid; 5: acetaminophen; NA= not applicable.

One infusion had unknown infusion reaction status.